On 01 December 1995, the former AMI Arzneimitteluntersuchungsinstitut-Nord GmbH in Emil-Sommer-Straße in Bremen commenced operations. On January 16, 2013, the company was renamed InphA GmbH and the institute underwent a strategic reorientation. Until then, the company had worked exclusively on behalf of its shareholders, but since then it has also been making its expertise available to third parties – provided that this does not impair the fulfilment of the tasks for the shareholders. To mark this occasion, the Senator for Health, Women and Consumer Protection issued a press release which you can read here (German only). At this point we would like to thank all our customers for their loyalty and support over the years. At the same time, we are confident about the future and look forward to continuing our cooperation.
- InphA’s services
- Consumer protection
01. September 2020Within the framework of the Global Health Protection Program (GHPP) of the German Federal Ministry of Health, InphA GmbH has been training employees from quality control laboratories of African drug authorities since 2017.>>>
21. August 2017The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) in Bonn and InphA GmbH are cooperating in the training of staff from Quality Control Laboratories from African Drug Supervisory Authorities in the field of drug analysis.>>>